Two Sigma Advisers’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.6K | Sell |
154,200
-2,900
| -2% | -$876 | ﹤0.01% | 2260 |
|
|
2025
Q1 | $44.8K | Sell |
157,100
-96,200
| -38% | -$27.4K | ﹤0.01% | 2325 |
|
|
2024
Q4 | $149K | Sell |
253,300
-84,300
| -25% | -$49.5K | ﹤0.01% | 2167 |
|
|
2024
Q3 | $151K | Sell |
337,600
-23,300
| -6% | -$10.4K | ﹤0.01% | 2121 |
|
|
2024
Q2 | $956K | Sell |
360,900
-8,600
| -2% | -$22.8K | ﹤0.01% | 1572 |
|
|
2024
Q1 | $1.01M | Buy |
369,500
+70,900
| +24% | +$194K | ﹤0.01% | 1575 |
|
|
2023
Q4 | $726K | Buy |
298,600
+19,500
| +7% | +$47.4K | ﹤0.01% | 1775 |
|
|
2023
Q3 | $564K | Sell |
279,100
-35,400
| -11% | -$71.5K | ﹤0.01% | 1754 |
|
|
2023
Q2 | $928K | Sell |
314,500
-179,700
| -36% | -$530K | ﹤0.01% | 1569 |
|
|
2023
Q1 | $1.24M | Buy |
494,200
+162,100
| +49% | +$405K | ﹤0.01% | 1525 |
|
|
2022
Q4 | $1.05M | Sell |
332,100
-15,300
| -4% | -$48.5K | ﹤0.01% | 1542 |
|
|
2022
Q3 | $1.03M | Buy |
347,400
+241,800
| +229% | +$718K | ﹤0.01% | 1505 |
|
|
2022
Q2 | $322K | Buy |
105,600
+69,400
| +192% | +$212K | ﹤0.01% | 2091 |
|
|
2022
Q1 | $489K | Sell |
36,200
-9,600
| -21% | -$130K | ﹤0.01% | 1998 |
|
|
2021
Q4 | $597K | Sell |
45,800
-29,100
| -39% | -$379K | ﹤0.01% | 1831 |
|
|
2021
Q3 | $703K | Buy |
74,900
+39,400
| +111% | +$370K | ﹤0.01% | 1778 |
|
|
2021
Q2 | $364K | Sell |
35,500
-16,200
| -31% | -$166K | ﹤0.01% | 2071 |
|
|
2021
Q1 | $951K | Sell |
51,700
-5,700
| -10% | -$105K | ﹤0.01% | 1674 |
|
|
2020
Q4 | $1.97M | Buy |
+57,400
| New | +$1.97M | 0.01% | 1269 |
|